IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sector Gamma AS

Q4 2023 Holdings

Filed 2024-02-05 | 30 holdings | $412.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Medtronic PLC(MDT)SHSG5960L103$35.8M435,0758.7%
Pfizer Inc(PFE)COM717081103$31.5M1,093,4167.6%
Gilead Sciences Inc(GILD)COM375558103$31.0M382,3627.5%
Biogen Inc(BIIB)COM09062X103$26.5M102,2346.4%
Incyte Corp(INCY)COM45337C102$25.0M398,6996.1%
Bristol-Myers Squibb Co(BMY)COM110122108$19.2M374,6874.7%
GE Healthcare Technologies I(GEHC)COMMON STOCK36266G107$19.1M247,5314.6%
CVS Health Corp(CVS)COM126650100$17.3M219,0004.2%
Zimmer Biomet Holdings Inc(ZBH)COM98956P102$17.2M141,2184.2%
Cardinal Health Inc(CAH)COM14149Y108$16.6M164,3054.0%
Centene Corp del(CNC)COM15135B101$16.1M216,4163.9%
Tenet Healthcare Corp(THC)COM NEW88033G407$14.6M193,2793.5%
Edwards Lifesciences Corp(EW)COM28176E108$14.3M187,5563.5%
Elevance Health Inc(ELV)COM036752103$13.1M27,8073.2%
Baxter Intl Inc(BAX)COM071813109$12.7M328,1323.1%
Globus MED Inc(GMED)CL A379577208$12.5M234,3743.0%
Laboratory Corp Amer HldgsCOM NEW50540R409$11.5M50,6862.8%
Bruker Corp(BRKR)COM116794108$9.4M127,3122.3%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$8.3M86,2472.0%
Qiagen NV(QGEN)SHS NEWN72482123$8.3M190,5392.0%
BIO RAD Labs Inc(BIO)CL A090572207$7.6M23,6091.8%
Ionis Pharmaceuticals Inc(IONS)COM462222100$7.3M145,0121.8%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$6.1M32,0921.5%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$5.9M188,1111.4%
Illumina Inc(ILMN)COM452327109$5.7M40,5921.4%
Alkermes PLC(ALKS)SHSG01767105$5.5M200,0001.3%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$4.9M102,4901.2%
Abbott Labs(ABT)COM002824100$4.4M39,8761.1%
Lantheus Hldgs Inc(LNTH)COM516544103$3.2M52,3160.8%
VIR Biotechnology Inc(VIR)COM92764N102$1.5M148,5380.4%